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Abstract
Background: The virtual screening (VS) of lead compounds using molecular docking and pharmacophore
detection is now an important tool in drug discovery. VS tasks typically require a combination of several software
tools and a molecular graphics system. Thus, the integration of all the requisite tools in a single operating
environment could reduce the complexity of running VS experiments. However, only a few freely available
integrated software platforms have been developed.
Results: A free open-source platform, IVSPlat 1.0, was developed in this study for the management and
automation of VS tasks. We integrated several VS-related programs into a molecular graphics system to provide a
comprehensive platform for the solution of VS tasks based on molecular docking, pharmacophore detection, and a
combination of both methods. This tool can be used to visualize intermediate and final results of the VS execution,
while also providing a clustering tool for the analysis of VS results. A case study was conducted to demonstrate
the applicability of this platform.
Conclusions: IVSPlat 1.0 provides a plug-in-based solution for the management, automation, and visualization of
VS tasks. IVSPlat 1.0 is an open framework that allows the integration of extra software to extend its functionality
and modified versions can be freely distributed. The open source code and documentation are available at http://
kyc.nenu.edu.cn/IVSPlat/.
Background
The successful application of virtual screening in drug dis-
covery means that medicinal chemists and pharmacolo-
gists are increasingly using this tool in drug discovery
research [1]. Two general strategies are employed in vir-
tual screening: (1) structure-based virtual screening
(SBVS) methods for screening compound libraries where
the three-dimensional (3D) structures of targets are avail-
able; and (2) ligand-based virtual screening (LBVS) meth-
ods for identifying potential hits in compound libraries,
typically where 3D target structures are unknown [2].
SBVS is dependent on knowledge of the 3D structure of
the target. The docking of a compound collection is tested
with the target structure and a quantified interaction score
is used to identify candidate lead compounds. Thus, SBVS
is not dependent on the existence of known active com-
pounds, which increases the prospects for identifying new
active lead compounds [3]. Several docking programs have
been developed for virtual screening since the initial devel-
opment of UCSF Dock [4,5], such as AutoDock [6],
GOLD [7], and GLIDE [8,9]. There have been reports of
the successful identification of lead compounds using
docking-based VS methods [10]. LBVS assumes that struc-
turally similar compounds are likely to exhibit similar bio-
logical activities. LBVS makes use of the physicochemical,
structural, and energetic properties of known active com-
pounds when searching large compound libraries for
related or novel chemical compounds [11]. The pharma-
cophore-based database searching technique is a widely
used VS strategy [12], which relies on knowledge of the
biological activity of multiple hits when identifying key fea-
tures during a search. A pharmacophore is a spatial
arrangement of features that allows a compound to inter-
act with a target receptor at a specific binding mode.
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with versatile applications in rational drug design, such as
virtual screening, de novo design, lead optimization, and
ADME/Tox studies. Several algorithms and software tools
have been developed for pharmacophore detection
[13-19]. In practice, SBVS and LBVS can be used in com-
bination or separately, depending on the specific aim.
However, very few open-source platforms have integrated
both approaches for virtual screening [20].
In this study, we developed an integrated virtual
screening platform, IVSPlat 1.0, which is an easily oper-
ated PyMOL [21] plug-in that performs many practical
virtual screening tasks derived from UCSF Dock 6.5 [22]
and PharmaGist [18], while also providing the facility to
analyze results. Molecular visualization can be used to
highlight connectivity and important structural features
in interacting molecules, which is crucial for drug design.
IVSPlat 1.0 was developed to exploit PyMOL’s excep-
tional molecular viewing capabilities, which are seam-
lessly integrated with other programs. Thus, IVSPlat 1.0
facilitates molecular docking and pharmacophore studies,
which can be visualized in a PyMOL window. Further-
more, IVSPlat 1.0 is an open source framework, thereby
allowing developers to add other new open source com-
putational applications using a uniform graphical user
interface (GUI). IVSPlat 1.0 was written in Python and its
installation instructions and video demonstrations can be
found on the IVSPlat website.
Implementation
Related technologies
IVSPlat 1.0 integrates the programs detailed in the fol-
lowing sections and it also provides a uniform interface
for accessing these programs, which facilitates transpar-
ency for the user. Auxiliary software can also be incorpo-
rate provided that they are preinstalled, such as
Openbabel [23], DMS [24], Sphgen [6], and MPICH2
[25].
PyMol
PyMol is one of the most popular molecular visualization
programs. The core of the program is a full-featured
Python [26] interpreter, which is extended by an OpenGL
3D display, a Tcl/Tk based GUI, and a PyMol API that
facilitates plug-in creation. Several popular plug-in exten-
sions have been developed in the field of molecular inter-
actions. The APBS plug-in [27] provides an interface for
the popular adaptive Poisson-Boltzmann solver (APBS)
program, thereby giving easy access to electrostatics calcu-
lations, and visualization of potential energy surfaces and
charge densities on protein surfaces. PyDeT [28] is a
PyMOL plug-in for visualizing tessellations derived from
the protein structure and the source protein. PyETV [29]
is a PyMOL plug-in used for viewing, analyzing, and
manipulating the prediction of evolutionarily important
residues and sites in protein structures and their com-
plexes. The Autodock/Vina plug-in [30] provides an inter-
face between PyMOL and two popular docking programs,
Autodock and Autodock Vina [31], thereby facilitating
molecular docking, virtual screening, and binding site ana-
lysis via PyMOL.
UCSF Dock 6.5
UCSF Dock is one of the most frequently used molecu-
lar docking applications in VS studies [2]. The latest
version of UCSF Dock is version 6.5 (UCSF Dock 6.5).
The following new features have been added to UCSF
Dock 6.5: 1) an anchor can be selected by specifying an
a t o mi naf r a g m e n ta n dt h en u m b e ro fa n c h o r su s e d
can be limited during multi-anchor docking; 2) the new
scoring function (descriptor score) has been introduced,
which includes a hydrogen bond term and footprint
similarity scoring; and 3) PB/SA score has been general-
ized to some extent and efficiency improvements have
been included that make docking, rather than rescoring,
more tractable for nontrivial systems [22]. However, no
GUI tool is currently available for automating VS tasks
using UCSF Docks.
PharmaGist
IVSPlat 1.0 uses the freely available program Pharma-
Gist [18] for LBVS. PharmaGist is a virtual screening
method that is based on pharmacophore detection. Its
workflow is as follows: 1) specify a set of active com-
pounds; 2) generate candidate pharmacophores that are
solved using an algorithm via multiple flexible alignment
of the active compounds; and 3) perform pharmaco-
phore-based virtual screening. PharmaGist is highly effi-
cient and a typical run of up to 32 active compounds
takes from seconds to a few minutes using a standard
PC [18].
PaDEL-Descriptor
PaDEL [32] is an open source program that can calcu-
late 801 descriptors (667 1D/2D descriptors and 134 3D
descriptors) and 10 types of fingerprints. The descriptors
and fingerprints are calculated using the Chemistry
Development Kit [33] with additional descriptors and
fingerprints. These additions include atom type electro-
topological state descriptors, McGowan volume, molecu-
lar linear free energy relation descriptors, ring counts,
counts of chemical substructures identified by Laggner,
binary fingerprints, and counts of chemical substruc-
t u r e si d e n t i f i e db yK l e k o t aa n dR o t h .P u b C h e mf i n g e r -
prints options were used to produce molecular
descriptors in our platform.
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Hcluster [34] is a hierarchical clustering library devel-
oped in the Python language with the Scipy package
[35]. This library provides Python functions for agglom-
erative clustering, including the generation of hierarchi-
cal clusters from distance matrices, computation of
distance matrices from observation vectors, calculation
of cluster statistics, linkage cutting to generate flat clus-
ters, and cluster visualization with dendrograms. Hclus-
ter also provides algorithms for clustering, including,
linkage, single, complete, average, median, and Ward’s
method. Ward’s method is the most adaptive for mole-
cular clustering [36], so it was used as the default in our
platform. However, users can still select their own pre-
ferred method. Hcluster outputs a dendrogram to illus-
trate the cluster results.
Architecture of IVSPlat 1.0
Figure 1 shows that the architecture of the platform
consists of three layers: application layer, class interface
layer, and software entity layer. The class interface layer
includes a class library written in Python that constitu-
tes the core of the platform. Several software programs
are integrated with the molecular graphics system in the
software entity layer, while various virtual screening ser-
vices are provided in the application layer. Python is an
interactive, object-oriented, extensible programming lan-
guage with strong support for integration with other
languages, so it was selected as the main programming
tool to produce a uniform software environment for the
simultaneous application of various scientific programs.
The class library in the class interface layer has four
components: GUI class, software interface class, results
analysis class, and format reading class. The software
interface class is the core, which consists of the Threa-
d_run and IVSPlat classes. IVSPlat class is the main
class for calling other classes in all the methods used in
the application layer, including the thread distribution,
conversion of file formats between the integrated pro-
grams, database operation, and the analysis of the VS
results. The application layer is composed of a GUI and
three functional modules. The GUI provides functions
for visualizing the binding geometries and interactions
between ligands (compounds) and receptors using
PyMOL, while the three functional modules allow dock-
ing-based VS, pharmacophore-based VS, and VS results
analysis. The platform is launched by running PyMOL
and it allows the user to specify the runtime parameters.
T h em a i np l a t f o r ms c r e e ni ss h o w ni nF i g u r e2 ( a ) ,
which includes nine functional items: configuration,
grid, receptor, ligand, docking, analysis, pharmacophore,
cluster, and database management.
Molecular docking-based virtual screening
A molecular docking-based virtual screening task can be
conducted starting with a target protein and a large,
Figure 1 Architecture of the IVSPlat 1.0 VS platform.
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in the following sections.
Running environment configuration
This module defines the location and the environment
variables required for the execution of each program.
To facilitate system maintenance and reconfiguration, all
the correctly configured options can be saved to a text
file, which can be manually modified as required.
Receptor and ligand preparation
Receptor preparation in UCSF Dock 6.5 includes a series
of tasks, including, adding hydrogen atoms and charges,
protonating amines, deleting solvent molecules [37], and
localizing the receptor binding sites. These tasks are fre-
quently accomplished by manual operation and inspec-
tion. In particular, the localization of binding site(s) is
composed of three related operations: 1) generating the
molecular surface of the receptor using the DMS pro-
gram; 2) generating spheres surrounding the receptor
using the Sphgen program; and 3) selecting a subset of
spheres to represent the binding site(s) using the Spher-
e_selector program. In IVSPlat 1.0, the receptor func-
tional module provides a workbench with an interactive
GUI that automates the process of binding site prepara-
tion. Users are not required to consider the inputs and
outputs of all the intermediate processes. The resulting
binding site(s) can also be visualized and analyzed in a
PyMOL window (Figure 2(b)).
During the preparation of ligands (compounds), UCSF
Dock 6.5 and PharmaGist have to add charges and
hydrogen atoms to ligands in a MOL2 format. It is
recommended that all ligand structures used in VS
experiments are obtained from the ZINC database [38].
ZINC is the most popular free database for virtual
screening and it contains compounds that are commer-
cially available. Moreover, the charges and hydrogen
atoms have already been added to each compound in
the ZINC compound database. Therefore, our platform
does not require a functionality for adding charges and
Figure 2 Main applications of the IVSPlat 1.0 VS platform. (a) Main screen of the IVSPlat 1.0 platform. (b) Preparation of receptor binding site
(s). (c) Preparation of ligand database. (d) Definition of the grid box. (e) Docking-based VS panel with the docked results shown in a table. (f)
Pharmacophore-based VS panel with the results listed in a table. (g) Clustering panel and clustering results displayed as a dendrogram. (h)
Database management.
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selected via the PyMOL window in the ligand functional
module, before a compound database for virtual screen-
ing is set up (Figure 2(c)). This module also converts
other formats to MOL2 during ligand preparation by
calling the Openbabel program.
Grid generation
UCSF Dock 6.5 requires a rectangular box to generate a
grid file and the grid functional module provides a gra-
phical environment for defining the centre of the box,
adjusting the box size and position, and generating the
final box file. PyMOL defined the box centre by selecting
explicit coordinates or by specifying a PyMOL selection
(e.g., a reference ligand) to calculate the mean coordi-
nates of the atoms. The docking box can be displayed in
the PyMOL window while the size and the exact position
of the box can be adjusted depending on the user’s
requirements (Figure 2(d)).
Docking
Depending on a user’s computer configuration, UCSF
Dock 6.5 can be installed in several different running
modes, including, GNU, GNU parallel, and GNU parallel
pbsa [22]. UCSF Dock 6.5 also has a wealth of parameters
for tailoring a particular VS service, including a choice of
multiple scoring functions. UCSF Dock 6.5 typically runs
from the command line in a standard Unix shell and it
reads an input parameter file containing all the field/value
options. We created a standard input file known as dock.
in and a control panel is provided so users can conveni-
ently adjust the running parameters in a file (Figure 2(e)).
During docking experiments, the grid box size must be set
high enough to allow all poses of the ligands to lie within
the box, although excessively large grid boxes will waste
computational resources. Thus, we placed an option in the
control panel to facilitate trial and error, i.e., max_orienta-
tions. The primary score parameter option in the control
panel helps users to select an appropriate scoring function.
Furthermore, the parallel version of UCSF Dock 6.5 with a
PB/SA scoring function can be employed if users install
the OpenEye Toolkits [39], which are freely available to
most academic and government institutions.
Analysis of results
A series of output files are created after the docking task
is complete, including an anchor_and_grow_ranked.mol2
file containing the top scored ligands sorted using a score
function value. Users can list all the data in the anchor_-
and_grow_ranked.mol2 file as a table in the analysis
f u n c t i o n a lm o d u l e ,f o l l o w e db yl o a d i n gt h ed a t ai na
Pymol window to visualize and inspect ligand poses. In
general, the number of hits in a virtual screening task far
exceeds the number of compounds that can be
biologically tested, so a molecular clustering procedure is
required to reduce the number of hits to a subset of com-
pounds that best represents the overall result set. In IVS-
Plat 1.0, the Hcluster Python library and the PaDEL-
Descriptor program are used to produce a molecular
clustering module. The PaDEL-Descriptor program is
used to calculate the molecular descriptors and finger-
prints, while the Hcluster library is used to perform clus-
tering tasks based on the descriptors and fingerprints.
The clustering results are displayed in a hierarchical den-
drogram (Figure 2(g)), which can be saved as a text file.
Pharmacophore-based virtual screening
IVSPlat 1.0 provides a pharmacophore-based virtual
screening module via PharmaGist. The module is simple
and easy to use, and users are only required to upload a
ligand file and a compound database file as input, before
setting an optional running parameter, such as the scor-
ing weight of each feature. The module has two main
components: generating pharmacophores and screening
the compound database with the resulting pharmaco-
phore. The method is similar to that used in molecular
docking-based virtual screening. The pharmacophores
can be loaded and analyzed in a PyMOL window before
selecting the appropriate public pharmacophore (Figure
2(f)). An output such as *mol2_dbres.html (* means any
string) is created after the VS task is complete, which
contains each output compound’s score and structure
information. The screening results can be summarized as
a table in score order and these data can be visualized in
a PyMOL window (Figure 2(f)).
Combined virtual screening
Different VS approaches are characterized by their
screening strategies, i.e., SBVS or LBVS, which can be
used independently or in combination. Combined virtual
screening is regarded as a novel VS protocol that effi-
ciently increases hit rates during virtual screening, while
reducing the computational costs [40-42]. IVSPlat 1.0
provides an environment for combined virtual screening
using pharmacophore-based VS and molecular docking-
based VS. Pharmacophore-based VS can be used as pre-
filter during the virtual screening of a huge database,
before performing molecular docking-based VS only
with the top results obtained during the first step [40].
Pharmacophore-based VS and molecular docking-based
VS can also be used in parallel to improve the enrich-
ment factor (EF). An example is presented in the next
section to demonstrate the applicability of this platform.
Database management
All the input and output files used in the current ver-
sion of the IVSPlat platform are text files, including the
compound database files (*.mol2). A suite of text access
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issues in input/output files of the integrated software
tools. A Python interface to SQLite (a lightweight SQL
database) was developed, whi c hi sm a i n l yu s e db yI V S -
Plat 1.0 for the data management of VS output results
(Figure 2(h)). This provides a base for further extension.
Application of the platform - a case study
Experimental dataset
The experimental dataset was taken from the DUD data-
base [43,44], which was designed for testing docking
algorithms by providing challenging decoys. DUD con-
tains 2950 active compounds with 40 targets. We used
thrombin (PDB id: 1H8D, H chain) as the target protein
in our experiments. Thrombin is a trypsin-like serine
protease with a central role in thrombosis and haemosta-
sis and its inhibitors are potentially pharmacologically
important antithrombotics [45]. The X-ray crystal struc-
tures of thrombin are known and structures of many
small molecule inhibitors complexed with thrombin have
been identified [43-45]. We also used 72 compounds that
are active against thrombin and we randomly selected
1000 compounds as decoys. We tested the applicability
of the platform by conducting virtual screening of throm-
bin inhibitors using several screening strategies.
Screening for thrombin inhibitors using molecular
docking-based VS
The target protein (thrombin, PDB id: 1H8D) was pre-
pared using UCSF Chimera [38] by the following two
steps: 1) remove L chain, I chain (inhibitor), and water
molecules from the crystal structure of thrombin; and 2)
add all hydrogen atoms and all the Gasteiger atom
charges. The residues within 10.0 Å of the bound ligand
were defined as the active site. To reduce the collision
probability, the parameter min_anchor_size was set to 5.
The pruning_conformer_score_cutoff was set at 100, the
max_orientations was set at 1000, the maximum num-
ber of orientations to be scored was set at 1000, and the
grid box size was set at 10. We treated all compounds
as flexible using DOCK’s anchor-and-grow algorithm
while the grid energy scoring method was used to evalu-
ate compounds. UCSF Dock 6.5 in parallel mode was
used for the screening task (using a Dell precision
T7400 workstation with two processors: Intel Xeon
E5430 quad core). The total running time was c. 2 h.
The results were analyzed in terms of EF. EF is a com-
mon metric used for comparing virtual screening results,
which is defined as follows:
EF =
HITSsampled

Nsampled
HITStotal

Ntotal
(1)
where Ntotal is the number of compounds in the data-
base, HITStotal is the total number of known active com-
pounds, Nsampled is the number of top compounds to be
sampled, and HITSsampled is the number of known active
compounds found in the Nsampled compounds.
Molecular docking-based VS provided good perfor-
mance in the experiments. Figure 3 shows that the max-
imum EF was 14 with the top 1% of the database
(Figure 3(a)), while the frequency of thrombin-active
compounds in the top 1% of the total library was c. 15%
(Figure 3(b)). The frequency of active compounds that
were screened gradually increased as we increased the
percentage of the database that was sampled. In con-
trast, the EFs gradually decreased and c. 90% of the
active compounds was successfully screened from the
top 50% of the database (Figure 3(b)).
Screening thrombin inhibitors using pharmacophore-
based VS
The current version of PharmaGist can only handle up
to 32 compounds when generating pharmacophores, so
we separated the 72 compounds into eight equal groups
with nine compounds in each. We used the nine com-
pounds in each group as seeds for constructing eight
test datasets, by taking extra random samples from the
other groups. Thus, eight test datasets were constructed
and each dataset was again divided randomly into four
small groups that contained 32, 16, 8, and 4 compounds
respectively. The running parameters of PharmaGist
were set as follows: the number of output pharmaco-
phores was set at 2; the number of output results was
set at 1000; while other parameters were set at the
default values. The results for the first and fourth data-
set are shown in Figure 4. Figure 4(a-1) shows that the
32-compound group used for generating pharmaco-
phores performed better than the other cases. Its maxi-
m u me n r i c h m e n tf a c t o rw a s1 2 . 5w i t ht h et o p1 %f r o m
the database and it retrieved c. 90% of active com-
pounds from the top 50% in the database (Figure 4(a-
2)). The enrichment factor and the percentage of active
compounds found in the experiments declined steadily
as the number of compounds used for generating phar-
macophores was decreased. The first dataset was the
worst case in our experiments and Figure 4(b-1) and
Figure 4(b-2) show that the maximum enrichment factor
was 4.2 with the top 1% from the database (Figure 4(b-
1)) while 47% of the active compounds were retrieved
from the top 50% in the database (Figure 4(b-2)). The
results with other datasets are shown in Supplementary
Figure S1 (see Additional file 1). These data indicated
that the performance of the pharmacophore-based VS
generally tended to be influenced by the compounds
used to generate the pharmacophores. Thus, the quality
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in the pharmacophore-based VS.
Combination of the two VS protocols
Pharmacophore-based VS is suitable when a set of
known active compounds is available. The strength of
the pharmacophore-based VS is its high speed.
However, docking-based VS is more appropriate when
the structure of a protein target is known. Compared
with pharmacophore-based VS, docking-based VS is
more suitable for searching for active compounds with
novel scaffolds, although its running speed is generally
slow. A combination of both VS protocols may provide
a superior alternative to the single VS protocol when
Figure 3 EF of docking-based VS and the corresponding percentage of active compounds. EF of docking-based VS. (b) The corresponding
percentage of active compounds.
Figure 4 EF and corresponding percentages of active compounds with pharmacophore-based VS using the fourth and first datasets.
(a-1) EF of pharmacophore-based VS with the fourth experimental dataset. (a-2) The corresponding percentages of active compounds with the
fourth experimental dataset. (b-1) Enrichment factor when screening the first experimental dataset. (b-2) The corresponding percentages of
active compounds when screening the first experimental dataset. The plot shows the results with four ligand groups: 32 ligands (blue); 16
ligands (red); 8 ligands (green); and 4 ligands (purple).
Sun et al. Chemistry Central Journal 2012, 6:2
http://journal.chemistrycentral.com/content/6/1/2
Page 7 of 10the structure of the target protein and a set of known
active compounds are available. Table 1 shows the
results obtained with a combination of both protocols
with the fourth dataset. Figure 5 shows that 65 active
compounds were successfully screened using pharmaco-
phore- and docking- based VS. We found that 58 com-
pounds were screened with combination of both,
whereas 14 of the 72 active compounds were screened
when using only one of the two protocols. Screening
results for the remaining seven datasets are shown in
Supplementary Tables S1-S7 and Figures S2-S8 (see
Additional file 1). In summary, pharmacophore- and
docking- based VS identified some common active com-
pounds, but they also identified different individual
active compounds, indicating the complementary effects
of each method. Thus, a combination of both VS proto-
cols is feasible.
Pharmacophore-based methods can be used as a pre-
filter during the screening of large databases to reduce
data input with docking-based VS. Alternatively, the two
methods can be used in parallel to improve the hit rate
with VS.
Conclusions
IVSPlat 1.0 is a plug-in based software platform for the
management of VS tasks and the analysis of VS results,
which integrates pharmacophore-based VS, docking-
based VS, a molecular graphics system, and the analy-
sis of results in a single, user-friendly workbench. IVS-
Plat 1.0 is an open framework which provides the
potential for further development. Work is ongoing to
improve the platform and allows researchers to per-
form QSAR model-based VS, ADMET-based virtual
screening, and knowledge-based virtual screening.
Researchers can also use more auxiliary programs for
workbench construction and results analysis. Another
major feature of this project will be the development
of online updates. The platform will be updated on the
IVSPlat web page.
Availability and requirements
Project name: IVSPlat 1.0
Project home page: http://kyc.nenu.edu.cn/IVSPlat/
Operating system(s): Linux (Fedora 14)
Programming language: Python
Table 1 Screening results with the fourth dataset for the top 50% of the database using dock- and pharmacophore-
based VS, and a combination of both
No Dock Phar Both No Dock Phar Both No Dock Phar Both
1 √ xx2 5 √√ √49 √√ √
2 √√ √26 x √ x5 0 √√ √
3 √√ √27 √√ √51 √√ √
4 √√ √28 √√ √52 √√ √
5 √ xx2 9 √√ √53 √√ √
6 √ xx3 0 √√ √54 √√ √
7 √ xx3 1 √√ √55 √√ √
8 √ xx3 2 √√ √56 √√ √
9x √ x3 3 √√ √57 √√ √
10 x √ x3 4 √√ √58 x √ x
11 √√ √35 x √ x5 9 x√ x
12 √√ √36 √√ √60 x √ x
13 √√ √37 √√ √61 √√ √
14 √√ √38 √√ √62 √ xx
15 √√ √39 √√ √63 √√ √
16 √√ √40 √√ √64 √√ √
17 √√ √41 √√ √65 √√ √
18 √√ √42 √√ √66 √√ √
19 √√ √43 √√ √67 √√ √
20 √√ √44 √√ √68 √√ √
21 √√ √45 √√ √69 √√ √
22 √√ √46 √√ √70 √√ √
23 √√ √47 √√ √71 √√ √
24 √√ √48 √√ √72 √ xx
In the table, Nos 1 to 72 represent ligands 1 to 72. “√” indicates that the ligand was successfully screened out, whereas “×” indicates that the ligand was not
screened out.
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Page 8 of 10Other requirements: PyMOL (v 1.4.1), Dock 6.5,
Pharmagist, PaDEL-Descriptor, Hcluster (v 0.2.0),
NumPy (v 1.6), DMS, MPICH2 and Openbabel (v 2.3)
License: GNU GPL
Any restrictions to use by non-academics: Contact
authors
Additional material
Additional file 1: Supplementary experimental results. The file
contains Supplementary Tables S1 to S7 and Supplementary Figures S1
to S8.
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